Direct Flow Medical plans to use a newly acquired $50 million to commercialize its flagship transcatheter aortic valve implantation system.
California-based medtech company Direct Flow Medical landed $50 million in debt financing, planning on using the new funds to support commercialization of a new transcatheter aortic valve implantation system.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/O40ZOp
Cap comentari:
Publica un comentari a l'entrada